Publication | Open Access
Atypical haemolytic uraemic syndrome treated with the complement inhibitor eculizumab: the experience of the <scp>A</scp>ustralian compassionate access cohort
31
Citations
39
References
2015
Year
Eculizumab has been an effective therapy for aHUS in this cohort, including when other therapies have failed.
| Year | Citations | |
|---|---|---|
Page 1
Page 1